S. Katsutani

发表

Thrombospondin-bound Integrin-associated Protein (CD47) Physically and Functionally Modifies Integrin αIIbβ3 by Its Extracellular Domain*

T. Shimomura, K. Fujimura, T. Fujimoto, 2003, Journal of Biological Chemistry.

Monoclonal antibody IAC-1 is speciﬁc for activated (cid:1) 2 (cid:2) 1 and binds to amino acids 199 to 201 of the integrin (cid:1) 2 I-domain

M. Hoylaerts, J. Heemskerk, K. Vanhoorelbeke, 2004 .

Successful haploidentical stem cell transplantation with prophylactic administration of liposomal amphotericin B after invasive pulmonary zygomycosis

H. Asaoku, M. Itagaki, K. Iwato, 2017, Medical mycology case reports.

Efficacy and safety of rituximab in Japanese patients with relapsed chronic immune thrombocytopenia refractory to conventional therapy

Y. Miyakawa, Y. Ikeda, Y. Kanakura, 2015, International Journal of Hematology.

Lack of allelic exclusion and isotype switching in B cell chronic lymphocytic leukemia

A. Kimura, A. Sakai, Y. Takimoto, 2001, American journal of hematology.

Roles of Src-like adaptor protein 2 (SLAP-2) in GPVI-mediated platelet activation SLAP-2 and GPVI signaling.

H. Deckmyn, A. Kimura, K. Fujimura, 2010, Thrombosis research.

A Point Mutation in Glycoprotein IX Coding Sequence (Cys73(TGT) to Tyr(TAT)) Causes Impaired Surface Expression of GPIb/IX/V Complex in Two Families with Bernard-Souiier Syndrome

T. Mochizuki, T. Fujii, A. Kuramoto, 1996, Thrombosis and Haemostasis.

Disseminated mucormycosis in an acquired immunodeficiency syndrome (AIDS) patient.

A. Kimura, N. Takata, T. Fujii, 2003, Internal medicine.

Monoclonal antibody IAC-1 is specific for activated alpha2beta1 and binds to amino acids 199 to 201 of the integrin alpha2 I-domain.

M. Hoylaerts, J. Heemskerk, H. Deckmyn, 2004, Blood.

Oral eltrombopag for up to three years is safe and well-tolerated in Japanese patients with previously treated chronic immune thrombocytopenia: an open-label, extension study

Y. Miyakawa, Y. Ikeda, Y. Kanakura, 2013, International Journal of Hematology.

A lower starting dose of eltrombopag is efficacious in Japanese patients with previously treated chronic immune thrombocytopenia

Y. Miyakawa, Y. Ikeda, Y. Kanakura, 2012, Journal of thrombosis and haemostasis : JTH.

Oligoclonal accumulation of T cells in peripheral blood from patients with idiopathic thrombocytopenic purpura

A. Kuramoto, K. Fujimura, T. Takafuta, 1996, British journal of haematology.

Cloning and characterization of the gene encoding the murine glycoprotein V: the conserved thrombin-cleavable protein on platelet surface.

A. Kimura, K. Fujimura, T. Shimomura, 1998, Thrombosis research.

Hemodialysis together with peritoneal dialysis is one of the simplest ways to maintain adequacy in continuous ambulatory peritoneal dialysis.

H. Kawanishi, E. Sakikubo, S. Katsutani, 1999, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

New approaches for antithrombotic antiplatelet therapies.

G. R. Van de Walle, H. Deckmyn, H. Ulrichts, 2004, Current medicinal chemistry.

Novel alternatively spliced form of β3-endonexin

T. Shimomura, K. Fujimura, T. Fujimoto, 2002 .

Acquired factor V inhibitor after antibiotic treatment in a patient with pneumonia: a case report

N. Hattori, M. Yamasaki, M. Taniwaki, 2019, Annals of Hematology.

Thrombospondin-bound integrin-associated protein (CD47) physically and functionally modifies integrin alphaIIbbeta3 by its extracellular domain.

T. Shimomura, K. Fujimura, T. Fujimoto, 2003, The Journal of biological chemistry.